Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com And Uniti

By Zacks Investment ResearchStock MarketsMar 01, 2020 08:18PM ET
www.investing.com/analysis/the-zacks-analyst-blog-highlights-codiagnostics-vaxart-sprint-stampscom-and-uniti-200512383
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com And Uniti
By Zacks Investment Research   |  Mar 01, 2020 08:18PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
UK100
+0.61%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
US500
+1.59%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
+1.39%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
US2000
+1.09%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BAC
+4.49%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GS
+2.35%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

For Immediate Release

Chicago, IL – March 2, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Co-Diagnostics Inc. (NASDAQ:CODX) , VAXART INC. (NASDAQ:VXRT) , Sprint Corporation (NYSE:S) , Stamps.com Inc. (NYSE:S) and Uniti Group Inc. (NASDAQ:UNIT) .

Here are highlights from Friday’s Analyst Blog:

Market in Correction: 5 Stocks to Resist Coronavirus Attack

The final days of February have been brutal for global stocks, with U.S. stocks seeing steep losses for six days in a row. Three key U.S. indexes like the S&P 500, the Dow Jones and the Nasdaq lost more than 4% on Feb 27 on news that California is monitoring at least 8,400 people for the coronavirus. About 33 people have tested positive in the state.

Global stocks are bracing for the worst week since 2008, thanks to the virus scare. In the past week (as of Feb 27, 2020), the key U.S. indexes lost more than 11% and entered into the correction territory. The S&P 500 witnessed the fastest correction in history. The Dow Jones fell 1,190.95 points on Feb 27 — its worst single-day slump in history.The FTSE 100 is now on course for its worst week since the Eurozone debt crisis in 2011.

Global markets lost $1.83 trillion on Feb 27, with the U.S. markets shedding $1.33 trillion, S&P Dow Jones’ Howard Silverblatt said in an email. Over the past six days, global markets wiped out $6 trillion, with U.S. markets losing $4 trillion.

Bank of America (NYSE:BAC) commented that the global economy is on its way for its weakest year since the 2008 financial crisis due to increased lockdowns, restrictions on global travel and lower manufacturing activity in China. Also, Goldman Sachs (NYSE:GS) slashed its outlook for U.S. companies’ earnings growth to zero.

The three key big U.S. indexes and a small-cap index Russell 2000 tanked 9.3%, 10.7%, 7.9% and 9.1%, respectively (as of Feb 27, 2020). Against this backdrop, we highlight a few stocks that skyrocketed in the past month.

Co-Diagnostics Inc.— Up 207.9%

The molecular diagnostics company is clearly benefiting from the virus threat as it finalized its own unique coronavirus detection test. The new screening can test several patients at a time. This Zacks Rank #2 (Buy) companysurged 49.7% on Feb 27, the day Wall Street went into a correction mode.The stock hails from the favorable Zacks industry (top 46%) (read: The Wining Sector & Its Top Stocks in Virus-Infected January).

VAXART INC.— Up 128.9%

Vaxart is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Its development programs are oral tablet vaccines designed to provide protection against norovirus, seasonal influenza and respiratory syncytial virus. It also acts as a therapeutic vaccine for human papillomavirus.

No wonder, the company is in an advantageous position now as all expect a COVID-19 vaccine from it. It surged 49.7% on Feb 27. The stock has a Zacks Rank #2 andcomes from a favorable Zacks industry (top 39%).

Sprint Corporation— Up 109.4%

The wireless communications company’s stock has been gaining on the merger news. Sprint is poised to gain from potential growth opportunities of resilient 5G network rollout from its impending merger with T-Mobile. When the ruling in favor of Sprint-T Mobile deal (which was facing a regulatory hurdle) was announced on Feb.11, the stock surged. The Zacks Rank #3 (Hold) belongs to a favorable Zacks industry (top 41%).

Stamps.com Inc.— Up 86.4%

The Zacks Rank #1 (Strong Buy) company is a provider of Internet-based postage services. Stamps.com's service for postage online enables small businesses, enterprises and consumers print U.S. Postal Service-approved postage with just a PC, printer and Internet. The stock hails from a favorable Zacks industry (top 33%).

Uniti Group Inc.— Up 59.5%

The Zacks Rank #3 real estate investment trust company is engaged in the acquisition and construction of mission critical infrastructure in the communications industry.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



Sprint Corporation (S): Free Stock Analysis Report

Stamps.com Inc. (STMP): Free Stock Analysis Report

Uniti Group Inc. (UNIT): Free Stock Analysis Report

VAXART, INC. (VXRT): Free Stock Analysis Report

Co-Diagnostics, Inc. (CODX): Free Stock Analysis Report

Original post

Zacks Investment Research

The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com And Uniti
 

Related Articles

The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com And Uniti

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email